| Financial Year |
March 31 2023 |
| Monetary Funds |
528,485,650.72 |
| Held-for-trading Financial Assets |
365,783,539.15 |
| Notes Receivable |
4,064,320.00 |
| Accounts Receivable |
515,082,046.48 |
| Advances to Suppliers |
25,760,081.10 |
| Other Receivables |
58,495,066.87 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
384,712,097.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
37,121,478.59 |
| Total Current Assets |
1,930,796,174.44 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
107,009,281.14 |
| Investment Properties |
850,576,950.30 |
| Fixed Assetes |
331,975,299.20 |
| Under-construction Projects |
232,647,356.21 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
500,288,100.93 |
| R&D expenses |
-- |
| Goodwill |
12,357,362.97 |
| Long-Term Deferred and Prepaid Expenses |
8,284,774.40 |
| Deferred Income Tax Assets |
137,253,364.29 |
| Other Non-Current Assets |
35,301,303.86 |
| Sub-Total of Non-Current Assets |
2,255,448,616.48 |
| Total Assets |
4,186,244,790.92 |
| Short-Term Loans |
51,810,400.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
9,791,839.13 |
| Accounts Payable |
259,110,295.37 |
| Accounts Received In Advance |
8,411,518.77 |
| Employee Compensation Payable |
35,979,383.43 |
| Taxes Payable |
80,948,037.03 |
| Interest Payable |
-- |
| Dividend Payable |
90,771,775.80 |
| Other payables |
147,695,387.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
22,700,000.00 |
| Other Current Liabilities |
20,520,933.93 |
| Sub-Total of Current Liabilities |
827,701,674.18 |
| Long-term Loans |
109,320,007.10 |
| Bonds Payable |
197,207,396.98 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,900,834.55 |
| Deferred Income Tax Liabilities |
329,089.89 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
392,590,714.94 |
| Total Liabilities |
1,220,292,389.12 |
| Paid-In Capital(Or Share Stock) |
844,764,895.00 |
| Capital Surplus |
1,415,535,516.79 |
| Surplus Reserve |
49,062,374.44 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
585,728,134.69 |
| Minority Stockholder's Interest |
189,497,305.44 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,776,455,096.36 |
| Owner's Equity（Stockholder's Equity） |
2,965,952,401.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,186,244,790.92 |
